Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Cancelmi Daniel J	2. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [ THC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & Chief Financial Officer
(Last) (First) (Middle) 14201 DALLAS PARKWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 2/26/2021
(Street) DALLAS, TX 75254 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ⁽¹⁾	2/26/2021		M		14988	A	⁽²⁾	354925	D
Common Stock	2/26/2021		F		5933 ⁽³⁾	D	$51.02	348992	D
Common Stock ⁽⁴⁾	2/26/2021		M		9043	A	⁽²⁾	358035	D
Common Stock	2/26/2021		F		3559 ⁽³⁾	D	$51.02	354476	D
Common Stock ⁽⁵⁾	2/26/2021		M		12406	A	⁽²⁾	366882	D
Common Stock	2/26/2021		F		4882 ⁽³⁾	D	$51.02	362000	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
2020 February Restricted Stock Units	⁽¹⁾	2/26/2021		M			14988	⁽¹⁾	⁽¹⁾	Common Stock ⁽⁶⁾	14988	$0.00	29977	D
2019 February Restricted Stock Units	⁽⁴⁾	2/26/2021		M			9043	⁽⁴⁾	⁽⁴⁾	Common Stock ⁽⁶⁾	9043	$0.00	9044	D
2018 February Restricted Stock Units	⁽⁵⁾	2/26/2021		M			12406	⁽⁵⁾	⁽⁵⁾	Common Stock ⁽⁶⁾	12406	$0.00	0	D

Explanation of Responses:
(1)	As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 29,977 restricted stock units are shown in Table II, of which 14,988 are scheduled to vest on February 26, 2022, and 14,989 are scheduled to vest on February 26, 2023.
(2)	Restricted stock units convert into common stock on a one-for-one basis.
(3)	Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
(4)	As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock, as shown in Table I. The remaining 9,044 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022.
(5)	As previously reported, on February 28, 2018, the reporting person received a grant of 37,217 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2019, resulting in the vesting and settlement of 12,405 shares of common stock. The second anniversary occurred on February 28, 2020, resulting in the vesting and settlement of 12,406 shares of common stock. The third anniversary occurred on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend), resulting in the vesting and settlement of 12,406 shares of common stock, as shown in Table I.
(6)	Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Cancelmi Daniel J 14201 DALLAS PARKWAY DALLAS, TX 75254			EVP & Chief Financial Officer